BETA: Please send your feedback!
Med BioGene
MBI-CA:TSX
Biotechnology
$0
MICRO cap
$9.26
(0.01%)
-0.01%
since start of 2020
-6.42
- —
- 1
- 2
- 3
- 4
- 5
About
Biotechnology
Founded 2006
Med BioGene, Inc. operates as a life science company, which engages in the development and commercialization of genomic-based clinical laboratory diagnostic tests. It focuses on managing the license and rights to GeneFx Lung, a proprietary gene expression-based test for early-stage non-small-cell lung cancer. The company was founded on April 28, 2006 and is headquartered in Vancouver, Canada.
website
Headquarters
Executives
| Name | Title | Gender |
| Iain Weir-Jones, PhD | Chairman & Chief Executive Officer | Male |
| Ibrahim Ghobrial | Chief Financial Officer | Male |
Mindful Investing Summary
- —
- 1
- 2
- 3
- 4
- 5
Med BioGene - Competitors and Related Companies
How Med BioGene stacks up to its peers in the Biotechnology industry or with competing business segments.
Med BioGene
MBI-CA:TSX
Biotechnology
$0
MICRO cap
$9.26
(0.01%)
-0.01%
since start of 2020
-6.42
Loading…